February 2026– date –
-
New Series: Untangling Cancer Worries: Organ-by-Organ Basics at a Glance — Episode 6: Pancreatic Cancer—Why It’s Hard to Detect, and How Testing & Treatment Fit Together
“Pancreatic cancer is hard to detect.” “Symptoms are vague.” That uncertainty often fuels anxiety and a deep search spiral. This article provides a calm, plain-language overview of why early symptoms can be subtle, what symptoms may matt... -
Oncology Drug Approval News Flash: Zongertinib receives accelerated FDA approval for unresectable or metastatic HER2 TKD–mutated non-squamous non-small cell lung cancer in systemic therapy–naïve adults
FDA approval summary On February 26, 2026, the U.S. Food and Drug Administration (FDA) granted accelerated approval to the kinase inhibitor zongertinib (Hernexeos, Boehringer Ingelheim) for an expanded indication in adult patients with u... -
Oncology Drug Approval News Flash: Encorafenib plus cetuximab and fluorouracil-based chemotherapy receives traditional FDA approval for BRAF V600E–mutated metastatic colorectal cancer
FDA approval summary On February 24, 2026, the U.S. Food and Drug Administration (FDA) granted traditional approval to encorafenib (Braftovi, Array BioPharma Inc., a subsidiary of Pfizer Inc.) in combination with cetuximab and fluorourac... -
New Series: Untangling Cancer Worries: Organ-by-Organ Basics at a Glance — Episode 5: Prostate Cancer—Worried About Your PSA? A Calm Guide to Next Tests and Treatment Choices
“My PSA is high.” “My PSA keeps creeping up.” “They told me to repeat the test.” Prostate cancer often starts with a number, which can easily amplify worry. This article offers a calm, plain-language overview of what PSA can and cannot t... -
New Series Untangling Cancer Worries: Organ-by-Organ Basics at a Glance — Episode 3: Worried About Stomach Cancer? Understanding H. pylori, Endoscopy, and Follow-up Calmly
“My stomach feels uncomfortable.” “I’ve had indigestion for weeks.” “My screening result says I need follow-up.” “I tested positive for H. pylori.” Stomach cancer searches can quickly become overwhelming. This article offers a calm, plai... -
New Series: Untangling Cancer Worries: Organ-by-Organ Basics at a Glance — Episode 4: Breast Cancer—What to Know First After Noticing a Lump (The Testing Pathway)
“Is this a lump?” “Why does this side look different?” “There’s nipple discharge.” Breast cancer searches can quickly become overwhelming. This article is a calm, plain-language overview of the next steps: when to seek care, the typical ... -
New Series Episode 2: If Colorectal Cancer Is on Your Mind—A Calm, Gentle Overview of Symptoms, Tests, Staging, and Treatment | Untangling Cancer Worries: Organ-by-Organ Basics at a Glance
“I noticed blood in my stool.” “My bowel habits have changed.” “My screening stool test came back positive.” Once you start searching, the amount of information can feel overwhelming—and anxiety can grow. This article helps you organize ... -
New Series 1: Lung Cancer—A Calm Overview Before You Jump to Conclusions (Cough, Shortness of Breath, Tests, Staging) | Untangling Cancer Worries: Organ-by-Organ Basics at a Glance
“My cough won’t go away.” “I get short of breath.” “My health check X-ray showed a shadow.” Once you start searching, it’s easy to get overwhelmed and more anxious. This article is a calm, plain-language “map” of lung cancer basics—sympt... -
Series: Untangling Cancer Worries — Your First GuidePart 8: Lung Cancer Basics—A Calm Map of Tests, Staging, and Treatment Flow (With When-to-Seek-Care Signs)
Series: Untangling Cancer Worries — Your First Guide Even without medical knowledge, this series helps you calmly sort out what to check right now—for yourself or for someone you care about. “My cough won’t go away.” “I’m more short of b... -
Series: Untangling Cancer Worries — Your First GuidePart 7: How to Read “Breakthrough Treatment” News Without Panic—Focus Only on What Matters in Real Life
Series: Untangling Cancer Worries — Your First Guide Even without medical knowledge, this series helps you calmly sort out what to check right now—for yourself or for someone you care about. Headlines like “breakthrough cancer drug,” “a ... -
Series: Untangling Cancer Worries — Your First GuidePart 6: What Is a Rare Cancer? How to Search When Information Is Limited—and What to Ask Clinicians
Series: Untangling Cancer Worries — Your First Guide Even without medical knowledge, this series helps you calmly sort out what to check right now—for yourself or for someone you care about. When someone says “It’s a rare cancer,” the fe... -
Oncology Drug Approval News Flash: Optune Pax, a low electric field tumor treating fields device, approved with gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer
FDA approval summary On February 11, 2026, the U.S. Food and Drug Administration (FDA) approved a low electric field generator device, Optune Pax (Novocure), in combination with gemcitabine and nab-paclitaxel for the treatment of adult p... -
Series: Untangling Cancer Worries — Your First GuidePart 5: Genetic Variants and Cancer Risk — What Tests Can Tell You (and What They Can’t)
Series: Untangling Cancer Worries — Your First Guide Even without medical knowledge, this series helps you calmly sort out what to check right now—for yourself or for someone you care about. When you hear “There’s a genetic variant” or “... -
Series: Untangling Cancer Worries — Your First Guide Part 4: Benign vs Malignant Tumors — What the Words Mean (and What to Confirm First)
Series: Untangling Cancer Worries — Your First Guide Even without medical knowledge, this series helps you calmly sort out what to check right now—for yourself or for someone you care about. Seeing words like “tumor,” “benign,” and “mali... -
Series: Untangling Cancer Worries — Your First Guide Part 3: What Does “Metastasis” Mean? How It Differs From Stage—and How Treatment Plans Can Change
Series: Untangling Cancer Worries — Your First Guide Even without medical knowledge, this series helps you calmly sort out what to check right now—for yourself or for someone you care about. The word “metastasis” can make people freeze. ... -
Oncology Drug Approval News Flash: Pembrolizumab plus paclitaxel with or without bevacizumab approved for platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal carcinoma
FDA approval summary On February 10, 2026, the U.S. Food and Drug Administration (FDA) approved pembrolizumab (Keytruda, Merck) and pembrolizumab and berahyaluronidase alfa-pmph (Keytruda Qlex, Merck) in combination with paclitaxel, with... -
Series: Untangling Cancer Worries — Your First Guide Part 2: If Cancer Crosses Your Mind: 3 Things to Check First (with “When to Seek Care” signs)
Series: Untangling Cancer Worries — Your First Guide Even without medical knowledge, this series helps you calmly sort out what to check right now—for yourself or for someone you care about. The moment you think, “What if this is cancer?... -
Series: Untangling Cancer Worries — Your First Guide Part 1: When You’re Diagnosed With Cancer: What to Do (and Not Do) in the First Week — A Family-Friendly Question List
Series: Untangling Cancer Worries — Your First Guide Even without medical knowledge, this series helps you calmly sort out what to check right now—for yourself or for someone you care about. Hearing “It’s cancer” can make your mind go bl... -
From Beginner to Expert: AI in Drug Discovery – A Definitive Guide from Lab to Market (Extra Chapter, Snapshot as of November 22, 2025) focuses only on the latest AI-driven case studies and summarizes how far AI has actually progressed in real drug discovery and development.
1. Where Does AI in Drug Discovery Stand in 2025? Between 2024 and 2025, AI in drug discovery has quietly moved from the “proof-of-concept” phase into a stage where AI-designed molecules are showing signals in human trials. At the same t... -
From Beginner to Expert: AI in Drug Discovery – A Definitive Guide from Lab to Market (Part 7: “Putting It All Together”) summarizes a cross-modality roadmap for AI in drug discovery and development, clarifies what AI can and cannot realistically do, and outlines strategic considerations from lab bench to market access.
1. Recap: A Cross-Modality “AI in Drug Discovery” Map In Parts 1–6, we walked through: Small molecules × AI Antibodies, bispecifics, and ADCs × AI Nucleic acid and RNA therapeutics × AI Cell and gene therapies × AI Each time, we looked a...
12